The Ki-67 staining were scored as negative (<10%), weakly positive (<25%), positive (25%–50%), and strongly positive (>50%) in 39, 214, 122, and 75 breast cancer patients, respectively. This evidence concerns the gene MKI67 and breast carcinoma.